Current trials in DMD
The table below lists all DMD trials registered or updated on clinicaltrials.gov in the last 1000 days. Because it links directly to clinicaltrials.gov it is automatically updated whenever the information on clinicaltrials.gov changes.
Please note that TREAT-NMD can take no responsibility for the accuracy of the information below, which is pulled directly from clinicaltrials.gov.
Trials for DMD listed on clinicaltrials.gov
- Extension Study of NS-089/NCNP-02 in DMD
- A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3)
- Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
- A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 in Participants With Duchenne Muscular Dystrophy (DMD)
- The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD
- Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital
- Biomarker Development for Muscular Dystrophies
- Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
- CureDuchenne Link™: A Resource for Research
- Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD
- Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
- Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval
- The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy
- Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)
- Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy
- An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
- Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)
- The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD
- Brain Involvement in Dystrophinopathies Part 2
- A Phase 3 Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids, in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
